View Clinical Trial (Medical Research Study)
A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation - NCT01102114-(Clinical Trial 597195)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Charleston |
|
State:
|
|
WV |
| Zip Code: |
|
|
| Conditions: |
|
Smoking Cessation |
| Purpose: |
|
The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term
abstinence.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Current smoker who smokes at least 10 cigarettes a day during the past year and wants
to quit smoking.
- Smokers who are in good general health.
Exclusion Criteria:
- Prior exposure to NicVAX or any other nicotine vaccine.
- Use of systemic steroids.
- Cancer or cancer treatment in the last 5 years.
- HIV infection.
- History of drug or alcohol abuse or dependence within 12 months.
- Significant cardiovascular, hepatic, renal, psychiatric and/or respiratory disease.
- Inability to fulfill all visits for approximately 52 weeks. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
October 23, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|